Distribution Network Study and Implementation

April 6, 2016 476

boehringer_ingelheim_logo_svg

Description
Albert Boehringer started producing tartaric acid back in 1885 in a small factory in Ingelheim, close to the German city of Mainz. Now, over a century later, Boehringer Ingelheim is a major pharmaceutical company generating an annual turnover of more than 13 billion euros. Despite employing 44,000 people worldwide, Boehringer Ingelheim remains a family-owned company to this day.

Opportunities
Boehringer Ingelheim decided to merge its Belgian and Dutch operations, asking Groenewout to carry out a feasibility study to help optimize its logistics processes and support during the implementation.

Solution

  • Obtain data transparency on sales volumes, logistics-, transition costs and investments.
  • Provide a business case proving the efficiency of consolidation of the two warehouses.
  • Request for Quotation to potential Logistics Service Providers (LSP) .
  • Service Level Agreement with preferred LSP.
  • Project management during the implementation roll-out.

Benefits

  • One logistics and distribution operation for the entire Benelux region.
  • Optimal and more uniform operations.
  • Reduction in logistics costs.
Twitter
Unique Selling Points
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text.

Start typing and press Enter to search